Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zinc Supplementation for Regorafenib-Induced HFSR in mCRC
NCT03898102Phase 2Completed
- Sponsor
- Chang Gung Memorial Hospital
- Start
- Mar 2016
- Primary completion
- Mar 2019
- Modality
- Orthosteric Ligands
01
Overview
A Phase 2 trial of zinc gluconate in Hand-foot skin reaction (HFSR), sponsored by Chang Gung Memorial Hospital. Started Mar 2016; status: completed.
02
Drugs
zinc gluconate
03
Conditions
Hand-foot skin reaction (HFSR)
Beyond the preview
Go deeper on NCT03898102.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03898102.